Joseph Lustgarten - Concepedia

Author

Joseph Lustgarten

Mayo Clinic in Arizona

Also Known As

Joseph Lustgarten, Lustgarten, Joseph

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Sidney Kimmel Cancer Center Mayo Clinic Scripps Research Institute Weizmann Institute of Science

About

Joseph Lustgarten is an author at Mayo Clinic in Arizona specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	811
2	Immunology	11	12	793
3	Cell Biology	10	10	733
4	Pathology	2	2	42
5	Engineering	1	1	49

Joseph Lustgarten

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes Matthias Theobald, J Biggs, Javier Hernández, The Journal of Experimental Medicine ImmunologyImmune RegulationCell DeathImmunodominanceImmunoediting	1997	256
High Accumulation of T Regulatory Cells Prevents the Activation of Immune Responses in Aged Animals Sanjay Sharma, Ana Lucía Dominguez, Joseph Lustgarten The Journal of Immunology	2006	234
Flagellin Fusion Proteins as Adjuvants or Vaccines Induce Specific Immune Responses Camilo Cuadros, Francisco J. López‐Hernández, Ana Lucía Dominguez, Infection and Immunity	2004	187
Maximal T Cell–Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells Alicia González-Martín, Lucio Gómez, Joseph Lustgarten, Cancer Research	2011	125
Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8 Joseph Lustgarten, Matthias Theobald, Colleen Labadie, Human Immunology HistocompatibilityImmunogeneticsAutoimmune DiseaseHuman Leukocyte AntigenDouble Transgenic Mice	1997	105
Blockade of CCL1 Inhibits T Regulatory Cell Suppressive Function Enhancing Tumor Immunity without Affecting T Effector Responses Dominique B. Hoelzinger, Shannon E. Smith, Noweeda Mirza, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationNk CellsRegulatory T Cells	2010	104
Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti‐OX40 and anti‐4‐1BB monoclonal antibodies induces T cell–mediated protective immunity in Her‐2/neu transgenic mice Camilo Cuadros, Ana Lucía Dominguez, Pier‐Luigi Lollini, International Journal of Cancer	2005	91
The CD8<sup>+</sup> T cell repertoire against Her‐2/neu antigens in neu transgenic mice is of low avidity with antitumor activity Joseph Lustgarten, Ana Lucía Dominguez, Camilo Cuadros European Journal of Immunology	2004	71
Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses Shannon E. Smith, Dominique B. Hoelzinger, Ana Lucía Dominguez, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceT-regulatory CellImmune RegulationImmunologyIl-9 Production	2011	70
RETRACTED: Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth Soraya Zorro Manrique, María A. Duque-Correa, Dominique B. Hoelzinger, The Journal of Experimental Medicine	2011	66

Page 1